802 results on '"Mann, Kenneth G."'
Search Results
152. Erythrocyte Participation in Thrombin Generation
153. Clotting Factor Deficiency in Early Trauma-Associated Coagulopathy
154. Thrombin Generation in Hemorrhage Control and Vascular Occlusion
155. Active tissue factor and activated factor XI in patients with acute ischemic cerebrovascular events
156. Differences in the fractional abundances of carbohydrates of natural and recombinant human tissue factor
157. Dilutional Control of Prothrombin Activation at Physiologically Relevant Shear Rates
158. Bone Loss and Reduced Osteoblast Function in Primary Biliary Cirrhosis
159. No evidence for tissue factor on platelets
160. Taking the Thrombin “Fork”
161. The effects of flow on the activation of bovine prothrombin by prothrombinase at physiologically relevant shear rates
162. Carbohydrates and Activity of Natural and Recombinant Tissue Factor
163. Preparation and duties of North Carolina industrial arts teachers
164. Heterogeneity of human bone
165. Effect of acute increases in bone matrix degradation on circulating levels of bone-gla protein
166. Immunolocalization of noncollagenous bone matrix proteins in lumbar vertebrae from intact and surgically menopausal cynomolgus monkeys
167. Tissue Factor in Coagulation
168. Thromboelastography as a Better Indicator of Hypercoagulable State After Injury Than Prothrombin Time or Activated Partial Thromboplastin Time
169. The Nature of LPS-Stimulated Monocyte Tissue Factor Activity
170. Plasma Procofactor Activation by Factor Xla
171. Quantitation of Non-Inhibitory Anti-Factor VIII Antibodies in human Plasma
172. Predicting Thrombosis in Factor VLeiden Heterozygotes.
173. A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo
174. The Nature of the Stable Blood Clot Procoagulant Activities
175. Factor XIa and tissue factor activity in patients with coronary artery disease
176. Influence of bivalirudin on tissue factor-triggered coagulation
177. Predicting pharmacologic efficacy of anticoagulants
178. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions
179. The Resuscitative Fluid You Choose May Potentiate Bleeding
180. Cleavage of Factor Va Heavy Chain at Arg643 by Thrombin Partially Inactivates the Cofactor.
181. Citrate Blood a Century of Artifact.
182. Simulating blood coagulation: the contribution of α2‐macroglobulin and α1‐antitrypsin
183. The Tissue Factor Requirement in Blood Coagulation
184. Hemophilia and the Dynamics of Hemostasis.
185. Activated Protein C-Resistance Induced by a Low Molecular Weight Inhibitor.
186. Analyses of protein S function
187. Intracellular and Surface Distribution of Monocyte Tissue Factor
188. Simvastatin Given for 3 Days Can Inhibit Thrombin Generation and Activation of Factor V and Enhance Factor Va Inactivation in Hypercholesterolemic Patients
189. Statins and Blood Coagulation
190. Membrane-Bound and Soluble Tissue Factor - Fuse and Fire Extinguisher.
191. Quantitative Evaluation of Factor VIII in Factor VIII Products.
192. Quantitation of Natural, Recombinant, Cell-Surface and Plasma Tissue Factor.
193. Demystifying Tissue Factor.
194. The Resusciatative Fluid You Chose May Potentiate Bleeding.
195. The Factor V Activation Paradox
196. A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa
197. Thrombin
198. Structural Requirements for Expression of Factor Va Activity
199. Factor VII-Activating Protease
200. Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu Polymorphism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.